Certified by Founder Lodge
Aro Biotherapeutics
United States - Philadelphia, Pennsylvania
START UP
1 Disclosed Funding Rounds $41,500,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Unlocking the Potential of Genetic Medicines
Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a pl
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 29 ,2023 | Series B | $41,500,000 |
Northpond Ventures
HealthCap
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Forage | $40,000,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
